Abstract
Future Medicinal Chemistry invited a selection of experts to express their views on the current impact of big data in drug discovery and design, as well as speculate on future developments in the field. The topics discussed include the challenges of implementing big data technologies, maintaining the quality and privacy of data sets, and how the industry will need to adapt to welcome the big data era. Their enlightening responses provide a snapshot of the many and varied contributions being made by big data to the advancement of pharmaceutical science.
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Reference10 articles.
1. Open PHACTS. www.openphacts.org
2. SALT knowledge sharing. www.medchemica.com/salt.html
3. Matched Molecular Pair Analysis in drug discovery
4. Matched Molecular Pairs as a Medicinal Chemistry Tool
5. Session 3 (R&D): industry perspective on PPPs and the link between new business models and the regulatory framework. www.ema.europa.eu/docs/en_GB/document_library/Presentation/2013/11/WC500154182.pdf
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献